At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...

Nonalcoholic fatty liver disease (NAFLD) affects up to 40% of the population in western countries and is one of the most ...

Nat Clin Pract Gastroenterol Hepatol. 2009;6(1):18-19. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the Western world. NAFLD is associated with chronic ...

Using medical data from more than 1,200 people, specific microbiome signatures have been identified that allow precise ...

强强联合：司美格鲁肽联合二甲双胍显著改善t2dm合并nafld患者的肝脏炎症和胰岛β细胞功能 该研究为回顾性研究，纳入了2021年1月至2023年12月间接受 ...

Steatosis is diffuse in most patients with NAFLD, but occasionally it is focal. Consequently, US and CT may be misinterpreted as slowing malignant liver masses. In such cases, magnetic resonance ...

Non-alcoholic fatty liver disease can be accurately diagnosed by looking at a person’s gut microbiome signatures, scientists have said. Researchers can now predict if someone is at risk of developing ...